|
JP6261500B2
(ja)
|
2011-07-22 |
2018-01-17 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ヌクレアーゼ切断特異性の評価および改善
|
|
WO2014093709A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Methods, models, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof
|
|
EP2931899A1
(en)
|
2012-12-12 |
2015-10-21 |
The Broad Institute, Inc. |
Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof
|
|
DK2931897T3
(en)
|
2012-12-12 |
2018-02-05 |
Broad Inst Inc |
CONSTRUCTION, MODIFICATION AND OPTIMIZATION OF SYSTEMS, PROCEDURES AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND THERAPEUTICAL APPLICATIONS
|
|
EP3919505B1
(en)
|
2013-01-16 |
2023-08-30 |
Emory University |
Uses of cas9-nucleic acid complexes
|
|
US10760064B2
(en)
|
2013-03-15 |
2020-09-01 |
The General Hospital Corporation |
RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
|
|
WO2014204578A1
(en)
|
2013-06-21 |
2014-12-24 |
The General Hospital Corporation |
Using rna-guided foki nucleases (rfns) to increase specificity for rna-guided genome editing
|
|
AU2014227653B2
(en)
|
2013-03-15 |
2017-04-20 |
The General Hospital Corporation |
Using RNA-guided foki nucleases (RFNs) to increase specificity for RNA-guided genome editing
|
|
SI2986729T1
(sl)
|
2013-04-16 |
2019-02-28 |
Regeneron Pharmaceuticals, Inc. |
Ciljana sprememba genoma podgane
|
|
WO2014204724A1
(en)
|
2013-06-17 |
2014-12-24 |
The Broad Institute Inc. |
Delivery, engineering and optimization of tandem guide systems, methods and compositions for sequence manipulation
|
|
EP3725885A1
(en)
|
2013-06-17 |
2020-10-21 |
The Broad Institute, Inc. |
Functional genomics using crispr-cas systems, compositions methods, screens and applications thereof
|
|
MX2015017312A
(es)
|
2013-06-17 |
2017-04-10 |
Broad Inst Inc |
Suministro y uso de composiciones, vectores y sistemas crispr-cas para la modificación dirigida y terapia hepáticas.
|
|
EP3011030B1
(en)
|
2013-06-17 |
2023-11-08 |
The Broad Institute, Inc. |
Optimized crispr-cas double nickase systems, methods and compositions for sequence manipulation
|
|
KR20250012194A
(ko)
|
2013-06-17 |
2025-01-23 |
더 브로드 인스티튜트, 인코퍼레이티드 |
바이러스 구성성분을 사용하여 장애 및 질환을 표적화하기 위한 crispr-cas 시스템 및 조성물의 전달, 용도 및 치료 적용
|
|
US20150044192A1
(en)
|
2013-08-09 |
2015-02-12 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a cas9 nuclease
|
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
|
US9925248B2
(en)
|
2013-08-29 |
2018-03-27 |
Temple University Of The Commonwealth System Of Higher Education |
Methods and compositions for RNA-guided treatment of HIV infection
|
|
US9388430B2
(en)
|
2013-09-06 |
2016-07-12 |
President And Fellows Of Harvard College |
Cas9-recombinase fusion proteins and uses thereof
|
|
US9340799B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
MRNA-sensing switchable gRNAs
|
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
|
AU2014346559B2
(en)
|
2013-11-07 |
2020-07-09 |
Editas Medicine,Inc. |
CRISPR-related methods and compositions with governing gRNAs
|
|
US9546384B2
(en)
|
2013-12-11 |
2017-01-17 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for the targeted modification of a mouse genome
|
|
US20150165054A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting caspase-9 point mutations
|
|
JP6793547B2
(ja)
|
2013-12-12 |
2020-12-02 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
最適化機能ＣＲＩＳＰＲ−Ｃａｓ系による配列操作のための系、方法および組成物
|
|
EP3080259B1
(en)
|
2013-12-12 |
2023-02-01 |
The Broad Institute, Inc. |
Engineering of systems, methods and optimized guide compositions with new architectures for sequence manipulation
|
|
AU2014361781B2
(en)
|
2013-12-12 |
2021-04-01 |
Massachusetts Institute Of Technology |
Delivery, use and therapeutic applications of the CRISPR -Cas systems and compositions for genome editing
|
|
MX2016007325A
(es)
|
2013-12-12 |
2017-07-19 |
Broad Inst Inc |
Composiciones y metodos de uso de sistemas crispr-cas en desordenes debidos a repeticion de nucleotidos.
|
|
WO2015089364A1
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Crystal structure of a crispr-cas system, and uses thereof
|
|
BR112016013207A2
(pt)
*
|
2013-12-12 |
2017-09-26 |
Massachusetts Inst Technology |
administração, uso e aplicações terapêuticas dos sistemas crispr-cas e composições para o hbv e distúrbios e doenças virais
|
|
JP2017506893A
(ja)
*
|
2014-02-18 |
2017-03-16 |
デューク ユニバーシティ |
ウイルス複製不活化組成物並びにその製造方法及び使用
|
|
EP3149171A1
(en)
|
2014-05-30 |
2017-04-05 |
The Board of Trustees of The Leland Stanford Junior University |
Compositions and methods of delivering treatments for latent viral infections
|
|
DK3155101T3
(da)
|
2014-06-16 |
2020-05-04 |
Univ Johns Hopkins |
Sammensætninger og fremgangsmåder til ekspression af CRISPR-leder-RNA´er under anvendelse af H1-promotoren
|
|
WO2016022363A2
(en)
|
2014-07-30 |
2016-02-11 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
|
DK3207124T3
(da)
|
2014-10-15 |
2019-08-12 |
Regeneron Pharma |
Fremgangsmåder og sammensætninger til generering eller bevaring af pluripotente celler
|
|
ES2731437T3
(es)
|
2014-11-21 |
2019-11-15 |
Regeneron Pharma |
Métodos y composiciones para la modificación genética dirigida mediante el uso de pares de ARN guías
|
|
EP3889260A1
(en)
|
2014-12-12 |
2021-10-06 |
The Broad Institute, Inc. |
Protected guide rnas (pgrnas)
|
|
WO2016106244A1
(en)
|
2014-12-24 |
2016-06-30 |
The Broad Institute Inc. |
Crispr having or associated with destabilization domains
|
|
MA41382A
(fr)
|
2015-03-20 |
2017-11-28 |
Univ Temple |
Édition génique basée sur le système crispr/endonucléase à induction par tat
|
|
CN104726449A
(zh)
*
|
2015-03-23 |
2015-06-24 |
国家纳米科学中心 |
一种用于预防和/或治疗HIV的CRISPR-Cas9系统及其制备方法和用途
|
|
EP3300507A4
(en)
*
|
2015-04-02 |
2019-03-13 |
Agenovir Corporation |
GENERIC ADMINISTRATION AND COMPOSITIONS
|
|
US20180119174A1
(en)
|
2015-05-13 |
2018-05-03 |
Seattle Children's Hospita (dba Seattle Children's Research Institute |
Enhancing endonuclease based gene editing in primary cells
|
|
US20160346360A1
(en)
*
|
2015-05-29 |
2016-12-01 |
Agenovir Corporation |
Compositions and methods for cell targeted hpv treatment
|
|
US10117911B2
(en)
|
2015-05-29 |
2018-11-06 |
Agenovir Corporation |
Compositions and methods to treat herpes simplex virus infections
|
|
EP3325620A4
(en)
*
|
2015-05-29 |
2019-06-26 |
Agenovir Corporation |
ANTIVIRAL PROCEDURES AND COMPOSITIONS
|
|
EA037359B1
(ru)
*
|
2015-06-01 |
2021-03-17 |
Тэмпл Юниверсити - Оф Зе Коммонвэлс Систем Оф Хайе Эдьюкейшн |
Способы и композиции для рнк-направляемого лечения инфекции, вызываемой вич
|
|
CN104894071A
(zh)
*
|
2015-06-08 |
2015-09-09 |
东华大学 |
一种对gt1-7细胞进行基因编辑的方法
|
|
TWI813532B
(zh)
|
2015-06-18 |
2023-09-01 |
美商博得學院股份有限公司 |
降低脱靶效應的ｃｒｉｓｐｒ酶突變
|
|
WO2016205759A1
(en)
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation
|
|
US9512446B1
(en)
|
2015-08-28 |
2016-12-06 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
|
US9926546B2
(en)
|
2015-08-28 |
2018-03-27 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
|
AU2016316845B2
(en)
|
2015-08-28 |
2022-03-10 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
|
EP3356521A4
(en)
*
|
2015-09-28 |
2019-03-13 |
Temple University - Of The Commonwealth System of Higher Education |
METHOD AND COMPOSITIONS FOR RNA-TREATED TREATMENT OF HIV INFECTIONS
|
|
WO2017058888A1
(en)
*
|
2015-10-02 |
2017-04-06 |
Agenovir Corporation |
Transgenic nuclease systems and methods
|
|
EP4491732A3
(en)
|
2015-10-08 |
2025-03-26 |
President and Fellows of Harvard College |
Multiplexed genome editing
|
|
US20190083656A1
(en)
*
|
2015-10-16 |
2019-03-21 |
Temple University - Of The Commonwealth System Of Higher Education |
Methods and compositions utilizing cpf1 for rna-guided gene editing
|
|
JP7109784B2
(ja)
|
2015-10-23 |
2022-08-01 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
遺伝子編集のための進化したＣａｓ９蛋白質
|
|
EP3387001A4
(en)
|
2015-12-09 |
2019-08-14 |
Excision Biotherapeutics, Inc. |
GENETIZATION METHOD AND AGENT TO ELIMINATE THE RISK OF JC VIRUS ACTIVATION AND PML (PROGRESSIVE MULTIFOCALER LEUKOENCEEPHALOPATHY) DURING IMMUNOSUPPRESSIVE THERAPY
|
|
AU2017211062A1
(en)
*
|
2016-01-25 |
2018-06-07 |
Excision Biotherapeutics |
Methods and compositions for RNA-guided treatment of HIV infection
|
|
MX2018009904A
(es)
*
|
2016-02-15 |
2019-07-08 |
Univ Temple |
Escision de secuencias de acido nucleico retrovirales.
|
|
CA3015665C
(en)
*
|
2016-02-26 |
2020-09-22 |
Lanzatech New Zealand Limited |
Crispr/cas systems for c1-fixing bacteria
|
|
EP3219799A1
(en)
|
2016-03-17 |
2017-09-20 |
IMBA-Institut für Molekulare Biotechnologie GmbH |
Conditional crispr sgrna expression
|
|
JP2019519250A
(ja)
*
|
2016-05-10 |
2019-07-11 |
ユナイテッド ステイツ ガバメント アズ リプレゼンテッド バイ ザ デパートメント オブ ベテランズ アフェアーズＵｎｉｔｅｄ Ｓｔａｔｅｓ Ｇｏｖｅｒｎｍｅｎｔ Ａｓ Ｒｅｐｒｅｓｅｎｔｅｄ Ｂｙ Ｔｈｅ Ｄｅｐａｒｔｍｅｎｔ Ｏｆ Ｖｅｔｅｒａｎｓ Ａｆｆａｉｒｓ |
Ｈｉｖ−１感染と複製に必須な遺伝子を切断するｃｒｉｓｐｒ／ｃａｓの構築物のレンチウィルスによる送達
|
|
CN107365786A
(zh)
*
|
2016-05-12 |
2017-11-21 |
中国科学院微生物研究所 |
一种将spacer序列克隆至CRISPR-Cas9系统中的方法及其应用
|
|
IL323024A
(en)
|
2016-05-20 |
2025-10-01 |
Regeneron Pharma |
Methods for breaking immunological tolerance using multiple guide RNAs
|
|
WO2017210380A1
(en)
*
|
2016-06-01 |
2017-12-07 |
Excision Biotherapeutics, Inc. |
Compositions and methods of treatment for lytic and lysogenic viruses
|
|
CA3026332A1
(en)
*
|
2016-06-03 |
2017-12-14 |
Temple University - Of The Commonwealth System Of Higher Education |
Negative feedback regulation of hiv-1 by gene editing strategy
|
|
KR102547316B1
(ko)
|
2016-08-03 |
2023-06-23 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
아데노신 핵염기 편집제 및 그의 용도
|
|
US11661590B2
(en)
|
2016-08-09 |
2023-05-30 |
President And Fellows Of Harvard College |
Programmable CAS9-recombinase fusion proteins and uses thereof
|
|
US11542509B2
(en)
|
2016-08-24 |
2023-01-03 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
|
WO2018049372A1
(en)
*
|
2016-09-12 |
2018-03-15 |
Excision Biotherapeutics Inc |
Hiv clinical plan
|
|
KR101997116B1
(ko)
|
2016-10-14 |
2019-07-05 |
연세대학교 산학협력단 |
Kras 유전자에 상보적인 가이드 rna 및 이의 용도
|
|
WO2018070850A1
(ko)
*
|
2016-10-14 |
2018-04-19 |
연세대학교 산학협력단 |
Kras 유전자에 상보적인 가이드 rna 및 이의 용도
|
|
EP3526320A1
(en)
|
2016-10-14 |
2019-08-21 |
President and Fellows of Harvard College |
Aav delivery of nucleobase editors
|
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
|
US20190071673A1
(en)
*
|
2017-01-18 |
2019-03-07 |
Thomas Malcolm |
CRISPRs WITH IMPROVED SPECIFICITY
|
|
WO2018152418A1
(en)
*
|
2017-02-17 |
2018-08-23 |
Temple University - Of The Commonwealth System Of Higher Education |
Gene editing therapy for hiv infection via dual targeting of hiv genome and ccr5
|
|
JP2020510038A
(ja)
|
2017-03-09 |
2020-04-02 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
がんワクチン
|
|
EP3592853A1
(en)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Suppression of pain by gene editing
|
|
JP2020510439A
(ja)
|
2017-03-10 |
2020-04-09 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
シトシンからグアニンへの塩基編集因子
|
|
CN106755268B
(zh)
*
|
2017-03-22 |
2020-07-17 |
中国科学院海洋研究所 |
体外筛选具有改善记忆力的牡蛎活性肽的方法
|
|
CA3057192A1
(en)
|
2017-03-23 |
2018-09-27 |
President And Fellows Of Harvard College |
Nucleobase editors comprising nucleic acid programmable dna binding proteins
|
|
US20200140865A1
(en)
*
|
2017-04-17 |
2020-05-07 |
Temple University - Of The Commonwealth System Of Higher Education |
An hiv-1 eradication strategy employing nanoformulated anti-retroviral drugs and gene editing agents
|
|
WO2018195402A1
(en)
|
2017-04-20 |
2018-10-25 |
Egenesis, Inc. |
Methods for generating genetically modified animals
|
|
WO2018195545A2
(en)
|
2017-04-21 |
2018-10-25 |
The General Hospital Corporation |
Variants of cpf1 (cas12a) with altered pam specificity
|
|
WO2018209320A1
(en)
|
2017-05-12 |
2018-11-15 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
|
|
US20200172895A1
(en)
|
2017-05-25 |
2020-06-04 |
The General Hospital Corporation |
Using split deaminases to limit unwanted off-target base editor deamination
|
|
WO2019023680A1
(en)
|
2017-07-28 |
2019-01-31 |
President And Fellows Of Harvard College |
METHODS AND COMPOSITIONS FOR EVOLUTION OF BASIC EDITORS USING PHAGE-ASSISTED CONTINUOUS EVOLUTION (PACE)
|
|
EP3676376B1
(en)
|
2017-08-30 |
2025-01-15 |
President and Fellows of Harvard College |
High efficiency base editors comprising gam
|
|
KR20250107288A
(ko)
|
2017-10-16 |
2025-07-11 |
더 브로드 인스티튜트, 인코퍼레이티드 |
아데노신 염기 편집제의 용도
|
|
WO2019079819A1
(en)
*
|
2017-10-20 |
2019-04-25 |
City Of Hope |
COMPOSITION AND METHOD FOR ACTIVATION OF LATENT HUMAN IMMUNODEFICIENCY VIRUS (HIV)
|
|
WO2019118949A1
(en)
|
2017-12-15 |
2019-06-20 |
The Broad Institute, Inc. |
Systems and methods for predicting repair outcomes in genetic engineering
|
|
EP3797160A1
(en)
|
2018-05-23 |
2021-03-31 |
The Broad Institute Inc. |
Base editors and uses thereof
|
|
US12522807B2
(en)
|
2018-07-09 |
2026-01-13 |
The Broad Institute, Inc. |
RNA programmable epigenetic RNA modifiers and uses thereof
|
|
WO2020092453A1
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Nucleobase editors comprising geocas9 and uses thereof
|
|
US12351837B2
(en)
|
2019-01-23 |
2025-07-08 |
The Broad Institute, Inc. |
Supernegatively charged proteins and uses thereof
|
|
US20220194990A1
(en)
*
|
2019-01-31 |
2022-06-23 |
Board Of Regents Of The University Of Nebraska |
Virus-like particles and methods of use thereof
|
|
US11946040B2
(en)
|
2019-02-04 |
2024-04-02 |
The General Hospital Corporation |
Adenine DNA base editor variants with reduced off-target RNA editing
|
|
JP7657726B2
(ja)
|
2019-03-19 |
2025-04-07 |
ザ ブロード インスティテュート，インコーポレーテッド |
編集ヌクレオチド配列を編集するための方法および組成物
|
|
US12473543B2
(en)
|
2019-04-17 |
2025-11-18 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
WO2020237208A1
(en)
|
2019-05-23 |
2020-11-26 |
Christiana Care Health Services, Inc. |
Gene knockout of variant nrf2 for treatment of cancer
|
|
KR20220030945A
(ko)
|
2019-05-23 |
2022-03-11 |
크리스티아나 케어 헬스 서비시즈 인코포레이티드 |
암의 치료를 위한 nrf2의 유전자 녹아웃
|
|
MX2022004107A
(es)
*
|
2019-10-09 |
2022-08-10 |
Bluerock Therapeutics Lp |
Celulas con expresion transgenica sostenida.
|
|
US12435330B2
(en)
|
2019-10-10 |
2025-10-07 |
The Broad Institute, Inc. |
Methods and compositions for prime editing RNA
|
|
CN115867650A
(zh)
|
2020-04-20 |
2023-03-28 |
克里斯蒂安娜基因编辑研究公司 |
用于肺癌治疗的aav递送系统
|
|
DE112021002672T5
(de)
|
2020-05-08 |
2023-04-13 |
President And Fellows Of Harvard College |
Vefahren und zusammensetzungen zum gleichzeitigen editieren beider stränge einer doppelsträngigen nukleotid-zielsequenz
|
|
EP4179120A4
(en)
*
|
2020-07-13 |
2024-08-21 |
The United States Government as represented by the Department of Veterans Affairs |
Methods and compositions for crispr/cas9 guide rna efficiency and specificity against genetically diverse hiv-1 isolates
|
|
WO2022119919A1
(en)
*
|
2020-12-01 |
2022-06-09 |
Howell Alexandra |
Compositions and methods for cleaving viral genomes
|
|
EP4288541A1
(en)
|
2021-02-05 |
2023-12-13 |
Christiana Care Gene Editing Institute, Inc. |
Methods of and compositions for reducing gene expression and/or activity
|
|
US20250235555A1
(en)
|
2021-11-19 |
2025-07-24 |
Christiana Care Gene Editing Institute, Inc. |
Methods for intratumoral delivery of crispr/cas systems
|
|
US20250018060A1
(en)
|
2021-11-19 |
2025-01-16 |
Christiana Care Gene Editing Institute, Inc. |
Adenovirus delivery system for cancer treatment
|
|
US20230279442A1
(en)
|
2021-12-15 |
2023-09-07 |
Versitech Limited |
Engineered cas9-nucleases and method of use thereof
|
|
WO2023154451A1
(en)
|
2022-02-10 |
2023-08-17 |
Christiana Care Gene Editing Institute, Inc. |
Methods for lipid nanoparticle delivery of crispr/cas system
|
|
CN114657185B
(zh)
*
|
2022-03-28 |
2023-11-10 |
福州大学 |
一种基于适配体有序排列的金磁纳米探针及其在大田软海绵酸检测中的应用
|
|
CN115762764A
(zh)
*
|
2022-11-25 |
2023-03-07 |
中山大学附属第三医院 |
一种hiv阴性隐球菌脑膜炎治疗结局预测模型及其构建方法
|
|
WO2024130151A1
(en)
|
2022-12-16 |
2024-06-20 |
Christiana Care Gene Editing Institute, Inc. |
Compositions and methods for treating broad chemoresistance through chemoresistance-specific regulatory components
|
|
WO2025007140A2
(en)
|
2023-06-30 |
2025-01-02 |
Christiana Care Gene Editing Institute, Inc. |
Nras gene knockout for treatment of cancer
|
|
US20250319206A1
(en)
|
2024-04-04 |
2025-10-16 |
Christina Care Gene Editing Institute, Inc. |
Crispr/cas gene editing of neh4 and/or neh5 domains in nrf2
|
|
WO2025226816A1
(en)
|
2024-04-23 |
2025-10-30 |
Christiana Care Gene Editing Institute, Inc. |
Methods of identifying and correlating crispr-induced exon skipping to phenotypic outcomes
|
|
WO2026006542A2
(en)
|
2024-06-26 |
2026-01-02 |
Yale University |
Compositions and methods for crispr/cas9 based reactivation of human angelman syndrome
|